All cases of B-ALL with changes in JAK2 are accompanied by CRLF2 overexpression, facilitating the cytokine-receptor scaffolding necessary for this signaling [81]. This evidence concerns the gene CRLF2 and precursor B-cell acute lymphoblastic leukemia.